Coming Soon
Find comprehensive information on myomatous uterus, including clinical documentation, medical coding, ICD-10 codes (B57), uterine fibroids, leiomyoma, and myoma. Learn about diagnosis, treatment, and management of myomatous uterus for healthcare professionals and patients. Explore resources related to symptomatology, imaging, and differential diagnosis for a complete understanding of this common uterine condition.
Also known as
Leiomyoma of uterus
Benign tumors (fibroids) in the muscular wall of the uterus.
Other noninflammatory disorders of uterus
Includes other uterine conditions not classified elsewhere, such as adenomyosis.
Other benign neoplasms of uterus
Includes other benign growths in the uterus besides leiomyomas.
Pelvic and perineal pain
May be a symptom associated with uterine fibroids.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the myoma symptomatic?
When to use each related code
| Description |
|---|
| Uterine fibroids |
| Adenomyosis |
| Endometrial polyps |
Coding myomatous uterus without specifying location (submucosal, intramural, subserosal) leads to inaccurate documentation and potential downcoding.
Coding symptoms like bleeding or pain instead of the underlying myomatous uterus misrepresents the diagnosis and impacts quality metrics.
Lack of size documentation for myomatous uterus affects accurate coding, especially for procedures, and may trigger audits for medical necessity.
Patient presents with complaints consistent with symptomatic uterine fibroids (leiomyomas, myomas). Presenting symptoms include heavy menstrual bleeding (menorrhagia), prolonged menstrual periods (hypermenorrhea), pelvic pressure or pain, and urinary frequency. Physical examination reveals an enlarged, irregularly shaped uterus palpable on bimanual exam. Pelvic ultrasound confirms the presence of multiple uterine fibroids, the largest measuring [size] cm in diameter. Differential diagnosis includes adenomyosis, endometrial polyps, and pelvic masses. Assessment: Myomatous uterus (ICD-10 G25.1). Plan: Discussed treatment options including watchful waiting, medical management with nonsteroidal anti-inflammatory drugs (NSAIDs) for pain and hormonal therapy (e.g., GnRH agonists, oral contraceptives) to control bleeding, and surgical interventions such as uterine artery embolization (UAE) or myomectomy. Patient education provided regarding the risks and benefits of each option. Patient will follow up in [timeframe] to discuss treatment plan and symptom management. Medical coding and billing will reflect the evaluation and management (E/M) service provided, as well as the ultrasound procedure.